News Focus
News Focus
Replies to #67828 on Biotech Values
icon url

DewDiligence

10/27/08 4:00 PM

#67834 RE: mouton29 #67828

SVNT off 73% – you can tell from the nondescript
language in the PR header that the news is not good:

Savient's Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference

http://biz.yahoo.com/prnews/081027/ny41686.html
icon url

DewDiligence

10/27/08 4:01 PM

#67835 RE: mouton29 #67828

RDEA closed off 17% — perhaps guilt by association with SVNT?